Advertisement
Canada markets closed
  • S&P/TSX

    24,822.54
    +132.06 (+0.53%)
     
  • S&P 500

    5,864.67
    +23.20 (+0.40%)
     
  • DOW

    43,275.91
    +36.86 (+0.09%)
     
  • CAD/USD

    0.7246
    -0.0004 (-0.05%)
     
  • CRUDE OIL

    69.34
    -1.33 (-1.88%)
     
  • Bitcoin CAD

    94,296.36
    +190.27 (+0.20%)
     
  • XRP CAD

    0.74
    -0.01 (-1.27%)
     
  • GOLD FUTURES

    2,736.40
    +28.90 (+1.07%)
     
  • RUSSELL 2000

    2,276.09
    -4.76 (-0.21%)
     
  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     
  • NASDAQ

    18,489.55
    +115.94 (+0.63%)
     
  • VOLATILITY

    18.03
    -1.08 (-5.65%)
     
  • FTSE

    8,358.25
    -26.88 (-0.32%)
     
  • NIKKEI 225

    38,981.75
    +70.56 (+0.18%)
     
  • CAD/EUR

    0.6666
    -0.0024 (-0.36%)
     

Clorox (CLX) Reports Earnings Tomorrow: What To Expect

CLX Cover Image
Clorox (CLX) Reports Earnings Tomorrow: What To Expect

Consumer products giant Clorox (NYSE:CLX) will be announcing earnings results tomorrow after market close. Here's what to look for.

Clorox missed analysts' revenue expectations by 3% last quarter, reporting revenues of $1.81 billion, down 5.3% year on year. It was a mixed quarter for the company, with a solid beat of analysts' earnings estimates but a miss of analysts' organic revenue growth estimates.

Is Clorox a buy or sell going into earnings? Read our full analysis here, it's free.

This quarter, analysts are expecting Clorox's revenue to decline 3.4% year on year to $1.95 billion, a reversal from the 12.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.55 per share.

Clorox Total Revenue
Clorox Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Clorox has missed Wall Street's revenue estimates twice over the last two years.

Looking at Clorox's peers in the household products segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Colgate-Palmolive delivered year-on-year revenue growth of 4.9%, beating analysts' expectations by 1.1%, and WD-40 reported revenues up 9.4%, topping estimates by 6.3%. Colgate-Palmolive traded up 4.5% following the results while WD-40 was also up 4%.

Read our full analysis of Colgate-Palmolive's results here and WD-40's results here.

There has been positive sentiment among investors in the household products segment, with share prices up 3.4% on average over the last month. Clorox is down 1.2% during the same time and is heading into earnings with an average analyst price target of $145.3 (compared to the current share price of $132).

Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.